FTC approves Medtronic acquisition of Covidien

SHARE FTC approves Medtronic acquisition of Covidien
SHARE FTC approves Medtronic acquisition of Covidien

NEW YORK — The U.S. Federal Trade Commission said Wednesday that it approved Medtronic’s $42.9 billion acquisition of Covidien after the medical device maker agreed to sell a business that makes a type of catheter used in veins.

Medtronic said it will sell Covidien’s drug-coated balloon catheter business to Colorado Springs, Colorado-based The Spectranetics Corp. shortly after its acquisition of Covidien closes. Medtronic expects the deal to close early next year. It still needs to be cleared by regulators and authorization from Ireland, where Covidien is based. Both companies’ shareholders also need to approve the acquisition.

Medtronic first announced the deal to buy Covidien in June.

Shares of Minneapolis-based Medtronic shares rose 69 cents to close at $73.48 Wednesday. U.S.-traded shares of Covidien rose $1.22 to close at $100.54. Spectranetics shares rose 29 cents to close at $32.29.

The Latest
Sputtering White Sox offense gets 10 hits but goes 3-for-13 with runners in scoring position
The male, whose age was unknown, was taken to the University of Chicago Medical Center where he was pronounced dead.
Already this year there have been 203 mass shootings in America. History shows registration of powerful weapons can be an effective way to save lives
Employees for the Hispanic Housing Development Corporation referenced the ordinance in explaining to the local alderperson why they kept the heat on at the James Sneider Apartments in Rogers Park despite stifling temperatures last week.
In-person early voting starts May 26 in Chicago; June 1 for suburban Cook residents; and on Thursday for voters in Lake, DuPage, Will, Kane counties and other parts of Illinois.